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Abstract
Henoch-Schonlein Purpura (HSP) is one of the most common causes of small vessel vasculitis in 
children. A 6-year-old female presented with abdominal pain, swelling, and rashes over both the legs 
associated with multiple episodes of vomiting for around 10 days. Stool for the occult blood test was 
positive, but there was an absence of hematuria and albuminuria. The case was diagnosed as HSP 
and treated with dexamethasone for 10 days. The patient was finally discharged on the resolution of 
her symptoms. Early diagnosis and treatment favor the better outcome in cases without any renal 
complications.
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Introduction
Henoch-Schonlein Purpura (HSP), also known as 
IgA vasculitis, is a small vessel vasculitis with IgA1-
dominant immune deposits predominantly on 
capillaries, venules, or arterioles. It often involves 
skin and gastrointestinal system and may also cause 
arthritis.[1] It is commonly seen in children and 
characterized by palpable purpura more commonly 
located in the dependent body parts such as lower 
extremities and buttocks, arthritis/arthralgia, and 
bowel angina along with hematuria/proteinuria.[2] 
The various etiologies have been suggested such as 
varieties of pathogens, drugs, and environmental 
exposure among which Group A beta-hemolytic 
Streptococcus has been much studied.[3]
The natural history of the disease has self-
limiting course in most of the cases except 
that those of renal complications associated 
with it. Symptomatic treatment with non-
steroidal anti-inflammatory drugs along with 
the steroids will have the joint and abdominal 
pain relief.[4] Corticosteroids if given in the early 
course of disease can help to provide a better 
clinical outcome.[5] The prognosis is good, with 
exception of renal involvement that may need 
the follow-up till 6 months or longer.[6,7]
The exact prevalence of HSP in our settings 
has yet to be discovered, but various studies 
revealed it to be one of the important causes of 
childhood renal disease.[8,9]
Case Report
The case is reported after taking informed 
written consent from the patient’s mother. 
6-year-old female presented with the complaints 
of pain in abdomen, swelling, and rashes 
over the lower limbs associated with multiple 
episodes of vomiting for 10 days. Pain in the 
abdomen was localized around the umbilicus 
and was sudden in onset, intermittent in nature, 
non-radiating, and alleviated on lying flat on 
the bed. She developed swelling in both legs 
subsequently a day after abdominal pain along 
with the appearance of rashes starting from feet 
and progressing to thigh and buttocks. She also 
developed three to four episodes of vomiting in 
last 5 days. The vomiting was non-projectile and 
non-blood stained.
On examination, the general condition of the 
patient was fair and vitals were stable. The 
abdomen was soft and non-tender. Mild bilateral 
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non-pitting edema was present over both the legs. There was 
the presence of non-tender, non-blanching, purpuric rashes 
over both lower limbs, and extending up to the buttocks.
Laboratory tests showed leukocytosis with WBC count of 
12,000/mm3; neutrophils: 8800/mm3; lymphocyte: 3200/
mm3; platelets: 4,22,000/mm3; hemoglobin: 14 g/dl; ESR: 
12 mm/1st h; serum urea: 33 mg/dl; serum creatinine: 0.6 mg/
dl; sodium: 139 mmol/l; potassium: 4.6 mmol/l; CRP: 0.92 mg/l; 
urinalysis: No hematuria or proteinuria, and stool analysis 
showed the presence of occult blood. The plain X-ray abdomen 
and ultrasound abdomen/pelvis revealed no abnormalities.
Diagnosis of HSP was made in accordance with the American 
College of Rheumatology and European League Against 
Rheumatism (EuLAR) and Pediatric Rheumatology Society 
(PReS) criteria.[10,11]
She was treated with dexamethasone 0.14 mg/kg/dose 4 times 
a day intravenously for 5 days continuously and then tapered 
to 3 times a day for 3 days following by 2 times a day for next 
2 days.
The recovery from purpura and bilateral swelling of the legs was 
observed after treatment in the 2nd and 3rd week [Figures 1-3].
Discussion
Henoch-Schonlein Purpura (HSP) was first described by William 
Heberden in 1801. Later, Schonlein recognized the association 
between purpura and arthritis, whereas Henoch reported a 
case that also included gastrointestinal symptoms along with 
the renal involvement.[12] HSP is the most common vasculitis 
of the children. Half among all the cases occur before the age 
of five and males are affected twice as common as females.[13]
The exact etiology and pathogenesis of HSP are yet to be 
determined. Seasonal variation has been related with a high 
prevalence rate in autumn and winter.[2] However, the case 
described here was diagnosed in the spring season. It has also 
been proposed that various triggers such as bacterial and viral 
infections, vaccinations, drugs, and autoimmune mechanisms 
may result in the formation of an antigen and antibody 
complex and the deposition of such formed immune complex 
in the small vessels may activate the alternate complement 
pathway leading to neutrophil aggregation which results 
in inflammation and vasculitis.[14] Among all, the preceding 
infection of β-hemolytic Streptococcus has been one of the 
most studied cases. The positive throat cultures, as well as 
increased titers of anti-streptolysin O, have been often found in 
many patients.[3] The evidence of prior infection has not been 
recorded in the present case.
The patient generally presents with the classic tetrad of rashes, 
polyarthralgia, abdominal pain, and renal disease. The non-
blanching rashes clinically appear as a palpable purpura on 
the lower legs and arms.[13] The joint involvement is generally 
characterized by the pain and swelling of the joints, most 
Figure 1: Purpura and swelling of bilateral lower limbs in the 
1st week
Figure 2: Progress of purpura in the 2nd week after the 
admission of patient in hospital
Figure 3: 3rd week before the discharge from hospital
Adhikari: Case report of six year old female with Henoch-Schonlein Purpura
Journal of Medical Research and Innovation Volume 2, Issue 1, e000095
Direct Access: https://jmri.org.in/jmri/article/view/e000095
3
affecting the knees and ankles. The abdominal pain followed 
by vomiting and intestinal bleeding is the dominant features 
involving the gastrointestinal system. Microscopic hematuria 
and albuminuria are the prominent renal findings.[5,15]
Our case had the symptoms of rashes over both lower legs, 
pain in abdomen, and vomiting. Joint involvement was absent. 
Significant laboratory finding was occult blood test positive 
in stool. However, there were no signs of hematuria and 
albuminuria.
The diagnosis of HSP was made by American College of 
Rheumatology-1990 criteria [Table 1] and EuLAR/PReS - 2006 
criteria [Table 2].
The patient is said to have HSP if at least two of the four above 
criteria is present. In our case, there was the presence of 
palpable purpura, age <20 at disease onset and bowel angina, 
and thus was diagnosed as HSP.
The patient is said to have HSP if mandatory criteria are present 
along with at least one of the additional criteria. Our case 
fulfilled the mandatory criteria along with diffuse abdominal 
pain as the additional criteria.
There is a predominantly spontaneous resolution of all 
symptoms except that of the renal disease in the majority 
of the cases. Steroids are more often used for the relief of 
abdominal pain, joint pain, and skin disease. Alternatively, 
methotrexate and dapsone have been quite effective (steroid-
sparing agent) for the treatment of chronic abdominal pain and 
skin involvement.[4] The role of the corticosteroids in preventing 
the long-term outcome of renal complications is controversial. 
A meta-analysis in the Medline database and the Cochrane 
Controlled Trials Register based on a comprehensive review of 
the literature by Weiss et al. stated that early treatment with 
corticosteroid significantly reduces the odds of developing 
persistent renal disease along with surgical intervention and 
recurrence.[5] In contrary, other trials and updates in the literature 
have mentioned that there is no long-term renal protective 
outcome on the early treatment with prednisolone.[16,17]
In general, prednisolone is the commonly used steroid for the 
treatment of HSP. Although in our case, we used dexamethasone, 
there is no evidence in literature to prove the superiority of one over 
another. Several cases and studies have been reported resulting in 
better outcomes on treatment with dexamethasone.[18,19]
The renal involvement has a high morbidity and mortality; 
otherwise, the disease has better prognosis.[7] A systematic 
review by Narchi stated that even if urinalysis is normal at the 
presentation, follow-up urine testing should be continued for 
at least 6 months as 97% children will develop abnormal urine 
findings by that time.[6]
Rarely, few cases of complicated HSP as intussusceptions, 
gastrointestinal bleeding and with cardiac involvement have 
been reported.[18,20,21]
Conclusion
HSP being one of the most common vasculitides of the children 
and its classic presentation of palpable purpura, arthritis, 
abdominal involvement, and renal features makes the diagnosis 
quite easier. Early initiation of treatment with steroids will help 
in symptomatic relief and bring a positive outcome. The renal 
disease may need long-term follow-up; otherwise, the diseases 
have favorable prognosis.
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